San Antonio Breast Cancer Symposium 2013

Options
Girlstrong
Girlstrong Member Posts: 438

Well it looks like Dr. Slamon has done his research and the presentation regarding HER 2 treatment.  His findings support a 92% desease free survival at 38 months median follow up.   Great advances for us with HER 2!!!!!  Take a peek at the link. 
http://www.eurekalert.org/pub_releases/2013-12/aafc-sih120413.php

Comments

Categories